ALIVE Trial (NCT02931240)

Clinical Study of the BioVentrix Revivent System for Treatment of Left Ventricular Aneurysms (ALIVE)

A prospective, multi-center, dual-arm pivotal study of the BioVentrix Revivent TC System.  The Revivent TC System is indicated for patients referred for surgical treatment of left ventricular scar that is contiguous and includes both anterior and septal components.

PI: Samar Sheth, MD

SPONSOR: BioVentrix, Inc.